14-16 May
| Brussels, Belgium
Main Conference - Day Two
8:30 am - 8:50 am
EST
NETWORKING BREAKFAST
8:50 am - 9:00 am
EST
CHAIRPERSON’S OPENING REMARKS
Steven Jacobs -
President,
Global BioPharm Solutions, LLC
9:00 am - 10:00 am
EST
OPENING PANEL I THE FUTURE OUTLOOK
Alexandra Tsioni -
Associate Director, Clinical Supply Chain Global Team Lead,
TEVA
Alain Frix - Senior Director, CT Supply Chain Design & Management, Chorus @ Eli Lilly & Company
TRENDS & PREDICTIONS: WHAT WILL THE FUTURE OF THE CLINICAL TRIAL SUPPLY CHAIN LOOK LIKE IN TEN YEARS
The clinical trial supply chain has undergone significant changes, with new technologies, patient-centric approaches, and globalization affecting the way clinical trials are conducted. So how can we proactively shape the future clinical trial supply chain to respond to the challenges of tomorrow?
Core focus areas to include:
- The Technological Outlook: How can we strategically integrate emerging technologies such as artificial intelligence and advanced analytics to enhance efficiency and decision-making?
- Patient-Centric Approaches When exploring patient-centric approaches in the clinical trial supply chain, what steps can be taken to truly prioritize the patient experience?
- Globalisation Of The Clinical Trial Supply Chain: In what ways can we navigate the complexities of different regulatory landscapes and optimise logistics to ensure a smooth flow of supplies across borders?
- Sustainability in Clinical Trial Supply: How can the industry collaborate to minimise its environmental impact, and what are the potential benefits of incorporating sustainability into our supply chain strategies?
Alain Frix
Senior Director, CT Supply Chain Design & ManagementChorus @ Eli Lilly & Company
10:00 am - 10:30 am
EST
KEYNOTE I STRATEGIES TO ENHANCE DEMAND PLANNING, STREAMLINE OPERATIONS & ENSURE TRIAL SUCCESS
Niklas Mattson -
Director Comparator Management,
MSD
This session focuses on accelerating the development of new therapies by emphasizing triple relationships with wholesalers, comparator sourcing and manufacturers.
By maintaining a strategic balance, pharma companies can enhance demand planning, streamline operations, and ensure trial success.
Key Takeaways:
- Strategic Balance: The importance of maintaining relationships with comparator sourcing, wholesalers and manufacturers for a stable supply chain.
- Enhance Transparency: Strategies on how to engage with manufacturers to address specific trial needs and improve demand planning.
- Efficient Collaboration: Foster cooperation for streamlined operations and better availability of products for use in trial trials.
10:30 am - 11:00 am
EST
CONFERENCE DEBATE I CONFRONTING NIGHTMARES IN CLINICAL TRIAL SUPPLYBENCHMARKING SUCCESS IN AVOIDING COMMON PITFALLS & NIGHTMARES IN CLINICAL TRIAL SUPPLY
Steven Jacobs -
President,
Global BioPharm Solutions, LLC
For this session we come together as a conference body to confront those topics that are keeping us all awake at night. We’ll break into small groups, with each group tasked with sourcing the key pitfalls and challenges associated with each topic. Each group will then begin discussing novel ways such pitfalls can be avoided. The groups will be based on the following themes:
- Temperature Control Logistics
- Packaging I Distribution
- Clinical Concerns
We’ll then come together as a conference body to see what was discussed. Steve Jacobs will then lead a conference wide discussion, with participants offering up their ownexperiences and solutions in relation to each topic.
11:00 am - 11:30 am
EST
EXPANDING HORIZONS: INCREASING DIVERSITY IN CLINICAL TRAILS
Révérien Uwacu -
Clinical Trial Supply Freelance,
UCB
Key Takeaways:
- Understanding the Need for Diversity:
Highlight the importance of including diverse populations in clinical trials to improve drug efficacy, safety, and the generalizability of research findings.
- Challenges and Solutions:
Discuss the specific challenges in recruiting and retaining participants from underrepresented regions and groups.
- The Future of Clinical Trials: Envisioning a more inclusive approach that not only expands the geographical reach of trials but also ensures a broader representation of ethnicities, ages, and genetic backgrounds.
11:30 am - 12:00 pm
EST
MORNING REFRESHMENTS & INNOVATION SHOWCASE
12:00 pm - 12:45 pm
EST
INTERACTIVE ROUNDTABLE DISCUSSION GROUPS I EXPANDING HORIZONS FOR CLINICAL TRIAL SUPPLY
Ana-Zeralda Canals Hamann -
Senior Clinical Trial Supplies Manager,
Debiopharm
Costanza Carmi - Clinical Supply Lead, Chiesi Farmaceutici
Cinthia Travaglini - Head of Global Development - Supply Lead & Study Set Up, UCB
Karen Crooks - Associate Director, Clinical Supply Chain, IO Biotech
Piotr Grzonkowski - Clinical Supply Program Lead, AstraZeneca
Peter Sas - Associate Director Compliance & Continuous Improvement, Johnson & Johnson
INVESTIGATING NEW REGIONS & THERAPIES: SEIZING THE OPPORTUNITIES OF AN EXPANDING CLINICAL TRIAL SUPPLY ECOSYSTEM
How does it work? Choose a 45-minute discussion on a pressing clinical trial supply topic. Interact with your peers, identifying contemporary challenges and novel approaches to confronting them. Each roundtable is led by a subject matter expert.
Following the conclusion of the discussions, there will be a 30-minute feedback session, where the roundtable leaders will share the key findings that came out of their respective discussions.
The discussion groups are:
GROUP A - HOW CAN WE BREAK DOWN SILOED DECISION-MAKING IN CLINICAL TRIAL SUPPLY?
GROUP B - OVERCOMING THE SUPPLY CHAIN CHALLENGES IN EMERGING CLINICAL TRIAL REGIONS
GROUP C- INDUSTRY BEST PRACTICES AND EMERGING TECH FOR A GREENER FUTURE OF CLINICAL TRIALS
GROUP D - HOW DO WE STRENGTHEN OUR SUPPLY CHAINS IN A “VUCA” WORLD?
GROUP E - INDUSTRY BEST PRACTICES TRENDING & MITIGATING TEMPERATURE DEVIATIONS
GROUP F - IDENTIFYING & USING THE BEST INDUSTRY CLINICAL SUPPLY CHAIN METRICS
12:45 pm - 1:45 pm
EST
NETWORKING LUNCH
1:45 pm - 2:00 pm
EST
CLINICAL TRIAL SUPPLY PRIZE WINNERS ANNOUNCED!
2:00 pm - 2:30 pm
EST
APPLYING PATIENT CENTRICITY IN CLINICAL TRIALS - DEBUNKING THE MYTHS
Pauline Frank -
Chief Patient Connector,
Patient Co-Next
There is a lot of noise about patient centricity and engagement in the industry, but what do people who actually run clinical trials think about it? Assumptions and misperceptions are quite consistent among those who have not been actively involved in engaging with patients around clinical trial design and burden.
Join this session to discuss:
- What do patients actually think about, when considering participating in a clinical trial?
- Is the path to patient centricity in clinical trials really possible, even if not from "big Pharma"? What in reality does it require from clinical trial teams?
- What does this all mean for future clinical trial supply management?
2:30 pm - 3:30 pm
EST
MY BATTLE WITH HODGKIN’S LYMPHOMA
Carol Jarvis -
Patient,
Case Study
Carol Jarvis is a much in-demand session musician in the UK and a multi-award-winning trombonist, keyboard player, arranger, orchestrator and voiceover artist. She has toured, recorded and worked extensively with the likes of Sting, Queen, Seal, Rod Stewart, Amy Winehouse, Bon Jovi, Ellie Goulding and appeared on many renowned television programs with stars such as MUSE, Harry Connick Jr, Michael Bublé, Taylor Swift and so many more. Carol is often invited to play with internationally renowned ensembles and some of the world’s top orchestras such as the London Symphony Orchestra, all of the BBC Orchestras, and she can also frequently be found performing in London’s West End shows.
What makes her achievements all the more remarkable is that when she was 26, Carol with Hodgkin’s lymphoma. During her nine-and-a-half-year battle with the disease, Miss Jarvis underwent chemotherapy, radiotherapy and a stem cell transplant. After all these traditional methods of care had failed to completely cure her, she was eventually saved by a new drug.
In a powerful speech, Carol tells us her story.
3:30 pm - 3:30 pm
EST
CHAIRPERSON’S CLOSING REMARKS & END OF CLINICAL TRIAL SUPPLY FORUM 2024
